Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer
The Prostate, 10/07/09
Furukawa J et al. – This study reports the first preclinical proof–of–principle data that this novel IGF–IR ASO selectively suppresses IGF–1R expression, suppresses growth of CRPC tumors, and delays CRPC progression in vitro and in vivo.
Related Articles
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 72%
Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection
The Journal of Urology, 11/13/09
Relevance Score: 71%
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 71%
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men
The Prostate, 11/02/09
Relevance Score: 71%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 71%
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Strategies for molecular expression profiling in bladder cancer
Cancer and Metastasis Reviews, 12/15/09
Urothelial carcinoma transmission via kidney transplantation
Nephrology Dialysis Transplantation, 12/15/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Prostatic Ductal Adenocarcinoma: A Mini Review
Medical Principles and Practice, 12/15/09
Prostate-Specific Antigen, Prostate Cancer, and Disorders of Hemostasis
Seminars in Thrombosis and Hemostasis, 12/15/09
GREB1 tissue expression is associated with organ-confined prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/15/09
Article Search
Sponsor


See Latest Articles


